Genotype Analysis of Patients with Hereditary Factor X Deficiency Enrolled in 2 Phase 3 Studies of Pdfx, a New High-Purity Factor X Concentrate

被引：2
|
作者：
Mitchell, Mike [1 ]
Kavakli, Kaan [2 ]
Norton, Miranda [3 ]
Austin, Steve [4 ]
机构：
[1] St Thomas Hosp, Mol Haemostasis & Thrombosis, Viapath LLP, London, England
[2] Ege Univ, Sch Med, Dept Pediat Hematol, Izmir, Turkey
[3] Bio Prod Lab, Elstree, Herts, England
[4] St Georges Healthcare NHS Trust Haemophilia Ctr, London, England
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.3511.3511
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 38 条
  • [1] Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery
    Escobar, M. A.
    Auerswald, G.
    Austin, S.
    Huang, J. N.
    Norton, M.
    Millar, C. M.
    [J]. HAEMOPHILIA, 2016, 22 (05) : 713 - 720
  • [2] Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency
    Austin, S. K.
    Kavakli, K.
    Norton, M.
    Peyvandi, F.
    Shapiro, A.
    [J]. HAEMOPHILIA, 2016, 22 (03) : 419 - 425
  • [3] Safety and Efficacy of FACTOR X, a New High Purity Factor X Concentrate: A Phase III Study in Patients with Hereditary Factor X Deficiency
    Austin, S.
    Norton, M.
    [J]. HAEMOPHILIA, 2015, 21 (03) : E260 - E260
  • [4] Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in women and girls with hereditary factor X deficiency
    Kulkarni, R.
    James, A. H.
    Norton, M.
    Shapiro, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (05) : 849 - 857
  • [5] Safety of a new high purity factor X concentrate in the management of hereditary factor X deficiency
    Norton, M.
    Mitchell, W. B.
    Alvarez, M. T.
    Austin, S.
    Auerswald, G.
    Bermejo, N.
    Escobar, M.
    Kavakli, K.
    Millar, C.
    Oner, A.
    Pavord, S.
    Macdonald, S.
    Aldwinckle, T.
    [J]. HAEMOPHILIA, 2014, 20 : 53 - 53
  • [6] Use of a High-Purity Factor X Concentrate in Turkish Subjects with Hereditary Factor X Deficiency: Post Hoc Cohort Subanalysis of a Phase 3 Study
    Oner, Ahmet F.
    Celkan, Tiraje
    Timur, Cetin
    Norton, Miranda
    Kavakli, Kaan
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2018, 35 (02) : 129 - 133
  • [7] Use of a High-Purity Factor X (FX) Concentrate In Six Turkish Patients with Hereditary FX Deficiency
    Kavakli, K.
    Oner, A. F.
    Celkan, T.
    Timur, C.
    Norton, M.
    [J]. HAEMOPHILIA, 2016, 22 : 94 - 95
  • [8] Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency
    Austin, S. K.
    Brindley, C.
    Kavakli, K.
    Norton, M.
    Shapiro, A.
    [J]. HAEMOPHILIA, 2016, 22 (03) : 426 - 432
  • [9] Pharmacokinetics, safety, and efficacy of a new high-purity plasma-derived factor X concentrate in female subjects with hereditary factor X deficiency
    James, Andra
    Shapiro, Amy
    Norton, Miranda
    [J]. HAEMOPHILIA, 2016, 22 : 136 - 136
  • [10] Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high-purity plasma-derived factor X (pdFX) concentrate
    Liesner, R.
    Akanezi, C.
    Norton, M.
    Payne, J.
    [J]. HAEMOPHILIA, 2018, 24 (06) : 941 - 949
1234